These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 38640337)

  • 1. Role and molecular mechanism of Salvia miltiorrhiza associated with chemical compounds in the treatment of diabetes mellitus and its complications: A review.
    Li J; Liu J; Shi W; Guo J
    Medicine (Baltimore); 2024 Apr; 103(16):e37844. PubMed ID: 38640337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salvia miltiorrhiza in diabetes: A review of its pharmacology, phytochemistry, and safety.
    Jia Q; Zhu R; Tian Y; Chen B; Li R; Li L; Wang L; Che Y; Zhao D; Mo F; Gao S; Zhang D
    Phytomedicine; 2019 May; 58():152871. PubMed ID: 30851580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on all-cause mortality, cardiovascular deaths, and cardiovascular events in patients with diabetes mellitus: a meta-analysis.
    Cheng J; Zhang W; Zhang X; Han F; Li X; He X; Li Q; Chen J
    JAMA Intern Med; 2014 May; 174(5):773-85. PubMed ID: 24687000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EVALUATING THE PRESCRIPTION OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS OR RECEPTOR BLOCKERS IN PATIENTS WITH DIABETES IN JORDAN.
    Mayyas F; Bataineh W; Jarab A
    Endocr Pract; 2017 Nov; 23(11):1289-1296. PubMed ID: 28816537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological potential of the combination of Salvia miltiorrhiza (Danshen) and Carthamus tinctorius (Honghua) for diabetes mellitus and its cardiovascular complications.
    Orgah JO; He S; Wang Y; Jiang M; Wang Y; Orgah EA; Duan Y; Zhao B; Zhang B; Han J; Zhu Y
    Pharmacol Res; 2020 Mar; 153():104654. PubMed ID: 31945473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of Salvia miltiorrhiza and ligustrazine injection combined with ACEI/ARB on diabetic kidney disease: A systematic review and meta-analysis.
    Zhang Z; Luo L; Li X; Zhong Y
    Medicine (Baltimore); 2024 Feb; 103(8):e35853. PubMed ID: 38394516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salvia miltiorrhiza in Anti-diabetic Angiopathy.
    Yin Z; Wang X; Yang X; Chen Y; Duan Y; Han J
    Curr Mol Pharmacol; 2021; 14(6):960-974. PubMed ID: 33430756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers on All-Cause Mortality and Renal Outcomes in Patients with Diabetes and Albuminuria: a Systematic Review and Meta-Analysis.
    Wang K; Hu J; Luo T; Wang Y; Yang S; Qing H; Cheng Q; Li Q
    Kidney Blood Press Res; 2018; 43(3):768-779. PubMed ID: 29794446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Pharmacist Telephone Intervention to Identify Adherence Barriers and Improve Adherence Among Nonadherent Patients with Comorbid Hypertension and Diabetes in a Medicare Advantage Plan.
    Abughosh SM; Wang X; Serna O; Henges C; Masilamani S; Essien EJ; Chung N; Fleming M
    J Manag Care Spec Pharm; 2016 Jan; 22(1):63-73. PubMed ID: 27015053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers reduced dementia risk in patients with diabetes mellitus and hypertension.
    Kuan YC; Huang KW; Yen DJ; Hu CJ; Lin CL; Kao CH
    Int J Cardiol; 2016 Oct; 220():462-6. PubMed ID: 27390970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular and Renal Outcomes of Renin-Angiotensin System Blockade in Adult Patients with Diabetes Mellitus: A Systematic Review with Network Meta-Analyses.
    Catalá-López F; Macías Saint-Gerons D; González-Bermejo D; Rosano GM; Davis BR; Ridao M; Zaragoza A; Montero-Corominas D; Tobías A; de la Fuente-Honrubia C; Tabarés-Seisdedos R; Hutton B
    PLoS Med; 2016 Mar; 13(3):e1001971. PubMed ID: 26954482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of Salvia miltiorrhiza (Salvia miltiorrhiza Bunge) and ligustrazine injection in the adjuvant treatment of early-stage diabetic kidney disease: A systematic review and meta-analysis.
    Xie F; Zhang B; Dai S; Jin B; Zhang T; Dong F
    J Ethnopharmacol; 2021 Dec; 281():114346. PubMed ID: 34153447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin-converting enzyme inhibitors versus angiotensin II receptor blockers in acute ST-segment elevation myocardial infarction patients with diabetes mellitus undergoing percutaneous coronary intervention.
    Choi SY; Choi BG; Rha SW; Byun JK; Shim MS; Li H; Mashaly A; Choi CU; Park CG; Seo HS; Oh DJ; Jeong MH;
    Int J Cardiol; 2017 Dec; 249():48-54. PubMed ID: 28867244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contemporary Treatment Patterns and Clinical Outcomes of Comorbid Diabetes Mellitus and HFrEF: The CHAMP-HF Registry.
    Vaduganathan M; Fonarow GC; Greene SJ; DeVore AD; Kavati A; Sikirica S; Albert NM; Duffy CI; Hill CL; Patterson JH; Spertus JA; Thomas LE; Williams FB; Hernandez AF; Butler J
    JACC Heart Fail; 2020 Jun; 8(6):469-480. PubMed ID: 32387066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in patients with diabetes mellitus and non-ST-segment elevation myocardial infarction who underwent successful percutaneous coronary intervention.
    Byun JK; Choi BG; Rha SW; Choi SY; Jeong MH;
    Atherosclerosis; 2018 Oct; 277():130-135. PubMed ID: 30212681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is diabetes mellitus a wrongdoer to COVID-19 severity?
    Sarkar S; Das D; Borsingh Wann S; Kalita J; Manna P
    Diabetes Res Clin Pract; 2021 Aug; 178():108936. PubMed ID: 34217771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of angiotensin-converting enzyme inhibitors and angiotensin ii receptor blockers on all-cause mortality, cardiovascular deaths, and cardiovascular events in patients with diabetes mellitus. A meta-analysis].
    Divisón Garrote JA; Seguí Díaz M; Escobar Cervantes C
    Semergen; 2014 Oct; 40(7):399-400. PubMed ID: 25103068
    [No Abstract]   [Full Text] [Related]  

  • 18. A Chinese patent medicine Salvia miltiorrhiza depside salts for infusion combined with conventional treatment for patients with angina pectoris: A systematic review and meta-analysis of randomized controlled trials.
    Zhang Y; Xie Y; Liao X; Jia Q; Chai Y
    Phytomedicine; 2017 Feb; 25():100-117. PubMed ID: 28190464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Research progress on salvianolic acids of Salvia miltiorrhiza].
    Liang WY; Chen WJ; Yang GH; Zhu D; Mao X; Shao YY; Wu LF; Zhang XX; Zhang LZ
    Zhongguo Zhong Yao Za Zhi; 2016 Mar; 41(5):806-812. PubMed ID: 28875631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of new stroke or new myocardial infarction or death at 39-month follow up in patients with diabetes mellitus, hypertension, or both treated with and without angiotensin-converting enzyme inhibitors or angiotensin receptor blockers.
    Ravipati G; Aronow WS; Ahn C; Alappat RM; McClung JA; Weiss MB
    Am J Ther; 2009; 16(1):2-4. PubMed ID: 19114876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.